PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
A single dose of 300 mg whole plant powder significantly improved pulmonary function parameters (FVC, FEV1, PEFR, FEF25-75%), though the effect was less than standard bronchodilators [PMID:10433479].
Kantakari Avaleha and its granule form were evaluated for efficacy in patients with mild to moderate bronchial asthma [PMID:38075186].
Safety & adverse effects
Drug interactions
Evidence summary
PubMed sources
- 1.PMID: 24991071 (2013) — Evaluation of anti-inflammatory activity of Solanum xanthocarpum Schrad and Wendl (Kaṇṭakāri) extract in laboratory animals. · Ancient science of life
- 2.PMID: 37748096 (2023) — Terpenoid compounds from the fruits of Solanum virginianum. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 3.PMID: 41330956 (2025) — Exploring phenotypic stability for berry yield of Solasodine rich germplasm accessions of Kantakari (Solanum virginianum L.), using AMMI stability model. · Scientific reports
- 4.PMID: 38031596 (2023) — Biogenic synthesis of AuNPs using Solanum virginianum L. and their antibacterial, antioxidant and catalytic applications. · Indian journal of microbiology
- 5.PMID: 38075186